Global Bio-based Pentylenediamine Market Insights, Forecast to 2029
This report presents an overview of global market for Bio-based Pentylenediamine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Bio-based Pentylenediamine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Bio-based Pentylenediamine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bio-based Pentylenediamine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bio-based Pentylenediamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bio-based Pentylenediamine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Bio-based Pentylenediamine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Bio-based Pentylenediamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Bio-based Pentylenediamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-based Pentylenediamine sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
This report researches the key producers of Bio-based Pentylenediamine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Bio-based Pentylenediamine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bio-based Pentylenediamine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bio-based Pentylenediamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bio-based Pentylenediamine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc.
By Company
- Cathay Biotech Inc.
- Aphena Pharma Solutions
- Bio-Tech Pharmacal
- Goodwin Biotechnology
- Xenon Pharmaceuticals
- Nektar Therapeutics
- Midas Pharmaceuticals
- Kedrion Biopharma
- Xcelthera
- Anichem
- ALC Bio Innovations
- ACADIA Pharmaceuticals
- AbbVie Inc.
- Ology Bioservices
- QMI - Quality Management
- Biomiga
- Molecular Targeting Technologies
- Polyamide
- PDI
- Epoxy Curing Agent
- Organic Synthesis Intermediate
- Others
- Spinning
- Engineering Materials
- Medicine
- Pesticides
- Organic Synthesis
- Others
- North America
- Europe
- China
- Japan
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Bio-based Pentylenediamine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Bio-based Pentylenediamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Bio-based Pentylenediamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-based Pentylenediamine sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Bio-based Pentylenediamine Product Introduction
1.2 Market by Type
1.2.1 Global Bio-based Pentylenediamine Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Polyamide
1.2.3 PDI
1.2.4 Epoxy Curing Agent
1.2.5 Organic Synthesis Intermediate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bio-based Pentylenediamine Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Spinning
1.3.3 Engineering Materials
1.3.4 Medicine
1.3.5 Pesticides
1.3.6 Organic Synthesis
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL BIO-BASED PENTYLENEDIAMINE PRODUCTION
2.1 Global Bio-based Pentylenediamine Production Capacity (2018-2029)
2.2 Global Bio-based Pentylenediamine Production by Region: 2018 VS 2022 VS 2029
2.3 Global Bio-based Pentylenediamine Production by Region
2.3.1 Global Bio-based Pentylenediamine Historic Production by Region (2018-2023)
2.3.2 Global Bio-based Pentylenediamine Forecasted Production by Region (2024-2029)
2.3.3 Global Bio-based Pentylenediamine Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 EXECUTIVE SUMMARY
3.1 Global Bio-based Pentylenediamine Revenue Estimates and Forecasts 2018-2029
3.2 Global Bio-based Pentylenediamine Revenue by Region
3.2.1 Global Bio-based Pentylenediamine Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Bio-based Pentylenediamine Revenue by Region (2018-2023)
3.2.3 Global Bio-based Pentylenediamine Revenue by Region (2024-2029)
3.2.4 Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2029)
3.3 Global Bio-based Pentylenediamine Sales Estimates and Forecasts 2018-2029
3.4 Global Bio-based Pentylenediamine Sales by Region
3.4.1 Global Bio-based Pentylenediamine Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Bio-based Pentylenediamine Sales by Region (2018-2023)
3.4.3 Global Bio-based Pentylenediamine Sales by Region (2024-2029)
3.4.4 Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global Bio-based Pentylenediamine Sales by Manufacturers
4.1.1 Global Bio-based Pentylenediamine Sales by Manufacturers (2018-2023)
4.1.2 Global Bio-based Pentylenediamine Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bio-based Pentylenediamine in 2022
4.2 Global Bio-based Pentylenediamine Revenue by Manufacturers
4.2.1 Global Bio-based Pentylenediamine Revenue by Manufacturers (2018-2023)
4.2.2 Global Bio-based Pentylenediamine Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Bio-based Pentylenediamine Revenue in 2022
4.3 Global Bio-based Pentylenediamine Sales Price by Manufacturers
4.4 Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application
4.8 Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global Bio-based Pentylenediamine Sales by Type
5.1.1 Global Bio-based Pentylenediamine Historical Sales by Type (2018-2023)
5.1.2 Global Bio-based Pentylenediamine Forecasted Sales by Type (2024-2029)
5.1.3 Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
5.2 Global Bio-based Pentylenediamine Revenue by Type
5.2.1 Global Bio-based Pentylenediamine Historical Revenue by Type (2018-2023)
5.2.2 Global Bio-based Pentylenediamine Forecasted Revenue by Type (2024-2029)
5.2.3 Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
5.3 Global Bio-based Pentylenediamine Price by Type
5.3.1 Global Bio-based Pentylenediamine Price by Type (2018-2023)
5.3.2 Global Bio-based Pentylenediamine Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global Bio-based Pentylenediamine Sales by Application
6.1.1 Global Bio-based Pentylenediamine Historical Sales by Application (2018-2023)
6.1.2 Global Bio-based Pentylenediamine Forecasted Sales by Application (2024-2029)
6.1.3 Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
6.2 Global Bio-based Pentylenediamine Revenue by Application
6.2.1 Global Bio-based Pentylenediamine Historical Revenue by Application (2018-2023)
6.2.2 Global Bio-based Pentylenediamine Forecasted Revenue by Application (2024-2029)
6.2.3 Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
6.3 Global Bio-based Pentylenediamine Price by Application
6.3.1 Global Bio-based Pentylenediamine Price by Application (2018-2023)
6.3.2 Global Bio-based Pentylenediamine Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada Bio-based Pentylenediamine Market Size by Type
7.1.1 US & Canada Bio-based Pentylenediamine Sales by Type (2018-2029)
7.1.2 US & Canada Bio-based Pentylenediamine Revenue by Type (2018-2029)
7.2 US & Canada Bio-based Pentylenediamine Market Size by Application
7.2.1 US & Canada Bio-based Pentylenediamine Sales by Application (2018-2029)
7.2.2 US & Canada Bio-based Pentylenediamine Revenue by Application (2018-2029)
7.3 US & Canada Bio-based Pentylenediamine Sales by Country
7.3.1 US & Canada Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Bio-based Pentylenediamine Sales by Country (2018-2029)
7.3.3 US & Canada Bio-based Pentylenediamine Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 EUROPE
8.1 Europe Bio-based Pentylenediamine Market Size by Type
8.1.1 Europe Bio-based Pentylenediamine Sales by Type (2018-2029)
8.1.2 Europe Bio-based Pentylenediamine Revenue by Type (2018-2029)
8.2 Europe Bio-based Pentylenediamine Market Size by Application
8.2.1 Europe Bio-based Pentylenediamine Sales by Application (2018-2029)
8.2.2 Europe Bio-based Pentylenediamine Revenue by Application (2018-2029)
8.3 Europe Bio-based Pentylenediamine Sales by Country
8.3.1 Europe Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Bio-based Pentylenediamine Sales by Country (2018-2029)
8.3.3 Europe Bio-based Pentylenediamine Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China Bio-based Pentylenediamine Market Size by Type
9.1.1 China Bio-based Pentylenediamine Sales by Type (2018-2029)
9.1.2 China Bio-based Pentylenediamine Revenue by Type (2018-2029)
9.2 China Bio-based Pentylenediamine Market Size by Application
9.2.1 China Bio-based Pentylenediamine Sales by Application (2018-2029)
9.2.2 China Bio-based Pentylenediamine Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia Bio-based Pentylenediamine Market Size by Type
10.1.1 Asia Bio-based Pentylenediamine Sales by Type (2018-2029)
10.1.2 Asia Bio-based Pentylenediamine Revenue by Type (2018-2029)
10.2 Asia Bio-based Pentylenediamine Market Size by Application
10.2.1 Asia Bio-based Pentylenediamine Sales by Application (2018-2029)
10.2.2 Asia Bio-based Pentylenediamine Revenue by Application (2018-2029)
10.3 Asia Bio-based Pentylenediamine Sales by Region
10.3.1 Asia Bio-based Pentylenediamine Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Bio-based Pentylenediamine Revenue by Region (2018-2029)
10.3.3 Asia Bio-based Pentylenediamine Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Market Size by Type
11.1.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Market Size by Application
11.2.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country
11.3.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 Cathay Biotech Inc.
12.1.1 Cathay Biotech Inc. Company Information
12.1.2 Cathay Biotech Inc. Overview
12.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Cathay Biotech Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Cathay Biotech Inc. Recent Developments
12.2 Aphena Pharma Solutions
12.2.1 Aphena Pharma Solutions Company Information
12.2.2 Aphena Pharma Solutions Overview
12.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Aphena Pharma Solutions Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Aphena Pharma Solutions Recent Developments
12.3 Bio-Tech Pharmacal
12.3.1 Bio-Tech Pharmacal Company Information
12.3.2 Bio-Tech Pharmacal Overview
12.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Bio-Tech Pharmacal Recent Developments
12.4 Goodwin Biotechnology
12.4.1 Goodwin Biotechnology Company Information
12.4.2 Goodwin Biotechnology Overview
12.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Goodwin Biotechnology Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Goodwin Biotechnology Recent Developments
12.5 Xenon Pharmaceuticals
12.5.1 Xenon Pharmaceuticals Company Information
12.5.2 Xenon Pharmaceuticals Overview
12.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Xenon Pharmaceuticals Recent Developments
12.6 Nektar Therapeutics
12.6.1 Nektar Therapeutics Company Information
12.6.2 Nektar Therapeutics Overview
12.6.3 Nektar Therapeutics Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Nektar Therapeutics Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Nektar Therapeutics Recent Developments
12.7 Midas Pharmaceuticals
12.7.1 Midas Pharmaceuticals Company Information
12.7.2 Midas Pharmaceuticals Overview
12.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Midas Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Midas Pharmaceuticals Recent Developments
12.8 Kedrion Biopharma
12.8.1 Kedrion Biopharma Company Information
12.8.2 Kedrion Biopharma Overview
12.8.3 Kedrion Biopharma Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Kedrion Biopharma Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Kedrion Biopharma Recent Developments
12.9 Xcelthera
12.9.1 Xcelthera Company Information
12.9.2 Xcelthera Overview
12.9.3 Xcelthera Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Xcelthera Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Xcelthera Recent Developments
12.10 Anichem
12.10.1 Anichem Company Information
12.10.2 Anichem Overview
12.10.3 Anichem Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Anichem Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Anichem Recent Developments
12.11 ALC Bio Innovations
12.11.1 ALC Bio Innovations Company Information
12.11.2 ALC Bio Innovations Overview
12.11.3 ALC Bio Innovations Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 ALC Bio Innovations Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 ALC Bio Innovations Recent Developments
12.12 ACADIA Pharmaceuticals
12.12.1 ACADIA Pharmaceuticals Company Information
12.12.2 ACADIA Pharmaceuticals Overview
12.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 ACADIA Pharmaceuticals Recent Developments
12.13 AbbVie Inc.
12.13.1 AbbVie Inc. Company Information
12.13.2 AbbVie Inc. Overview
12.13.3 AbbVie Inc. Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 AbbVie Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 AbbVie Inc. Recent Developments
12.14 Ology Bioservices
12.14.1 Ology Bioservices Company Information
12.14.2 Ology Bioservices Overview
12.14.3 Ology Bioservices Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Ology Bioservices Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Ology Bioservices Recent Developments
12.15 QMI - Quality Management
12.15.1 QMI - Quality Management Company Information
12.15.2 QMI - Quality Management Overview
12.15.3 QMI - Quality Management Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.15.4 QMI - Quality Management Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 QMI - Quality Management Recent Developments
12.16 Biomiga
12.16.1 Biomiga Company Information
12.16.2 Biomiga Overview
12.16.3 Biomiga Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.16.4 Biomiga Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Biomiga Recent Developments
12.17 Molecular Targeting Technologies
12.17.1 Molecular Targeting Technologies Company Information
12.17.2 Molecular Targeting Technologies Overview
12.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.17.4 Molecular Targeting Technologies Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Molecular Targeting Technologies Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 Bio-based Pentylenediamine Industry Chain Analysis
13.2 Bio-based Pentylenediamine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Bio-based Pentylenediamine Production Mode & Process
13.4 Bio-based Pentylenediamine Sales and Marketing
13.4.1 Bio-based Pentylenediamine Sales Channels
13.4.2 Bio-based Pentylenediamine Distributors
13.5 Bio-based Pentylenediamine Customers
14 BIO-BASED PENTYLENEDIAMINE MARKET DYNAMICS
14.1 Bio-based Pentylenediamine Industry Trends
14.2 Bio-based Pentylenediamine Market Drivers
14.3 Bio-based Pentylenediamine Market Challenges
14.4 Bio-based Pentylenediamine Market Restraints
15 KEY FINDING IN THE GLOBAL BIO-BASED PENTYLENEDIAMINE STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Bio-based Pentylenediamine Product Introduction
1.2 Market by Type
1.2.1 Global Bio-based Pentylenediamine Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Polyamide
1.2.3 PDI
1.2.4 Epoxy Curing Agent
1.2.5 Organic Synthesis Intermediate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bio-based Pentylenediamine Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Spinning
1.3.3 Engineering Materials
1.3.4 Medicine
1.3.5 Pesticides
1.3.6 Organic Synthesis
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL BIO-BASED PENTYLENEDIAMINE PRODUCTION
2.1 Global Bio-based Pentylenediamine Production Capacity (2018-2029)
2.2 Global Bio-based Pentylenediamine Production by Region: 2018 VS 2022 VS 2029
2.3 Global Bio-based Pentylenediamine Production by Region
2.3.1 Global Bio-based Pentylenediamine Historic Production by Region (2018-2023)
2.3.2 Global Bio-based Pentylenediamine Forecasted Production by Region (2024-2029)
2.3.3 Global Bio-based Pentylenediamine Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 EXECUTIVE SUMMARY
3.1 Global Bio-based Pentylenediamine Revenue Estimates and Forecasts 2018-2029
3.2 Global Bio-based Pentylenediamine Revenue by Region
3.2.1 Global Bio-based Pentylenediamine Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Bio-based Pentylenediamine Revenue by Region (2018-2023)
3.2.3 Global Bio-based Pentylenediamine Revenue by Region (2024-2029)
3.2.4 Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2029)
3.3 Global Bio-based Pentylenediamine Sales Estimates and Forecasts 2018-2029
3.4 Global Bio-based Pentylenediamine Sales by Region
3.4.1 Global Bio-based Pentylenediamine Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Bio-based Pentylenediamine Sales by Region (2018-2023)
3.4.3 Global Bio-based Pentylenediamine Sales by Region (2024-2029)
3.4.4 Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global Bio-based Pentylenediamine Sales by Manufacturers
4.1.1 Global Bio-based Pentylenediamine Sales by Manufacturers (2018-2023)
4.1.2 Global Bio-based Pentylenediamine Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bio-based Pentylenediamine in 2022
4.2 Global Bio-based Pentylenediamine Revenue by Manufacturers
4.2.1 Global Bio-based Pentylenediamine Revenue by Manufacturers (2018-2023)
4.2.2 Global Bio-based Pentylenediamine Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Bio-based Pentylenediamine Revenue in 2022
4.3 Global Bio-based Pentylenediamine Sales Price by Manufacturers
4.4 Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application
4.8 Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global Bio-based Pentylenediamine Sales by Type
5.1.1 Global Bio-based Pentylenediamine Historical Sales by Type (2018-2023)
5.1.2 Global Bio-based Pentylenediamine Forecasted Sales by Type (2024-2029)
5.1.3 Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
5.2 Global Bio-based Pentylenediamine Revenue by Type
5.2.1 Global Bio-based Pentylenediamine Historical Revenue by Type (2018-2023)
5.2.2 Global Bio-based Pentylenediamine Forecasted Revenue by Type (2024-2029)
5.2.3 Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
5.3 Global Bio-based Pentylenediamine Price by Type
5.3.1 Global Bio-based Pentylenediamine Price by Type (2018-2023)
5.3.2 Global Bio-based Pentylenediamine Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global Bio-based Pentylenediamine Sales by Application
6.1.1 Global Bio-based Pentylenediamine Historical Sales by Application (2018-2023)
6.1.2 Global Bio-based Pentylenediamine Forecasted Sales by Application (2024-2029)
6.1.3 Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
6.2 Global Bio-based Pentylenediamine Revenue by Application
6.2.1 Global Bio-based Pentylenediamine Historical Revenue by Application (2018-2023)
6.2.2 Global Bio-based Pentylenediamine Forecasted Revenue by Application (2024-2029)
6.2.3 Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
6.3 Global Bio-based Pentylenediamine Price by Application
6.3.1 Global Bio-based Pentylenediamine Price by Application (2018-2023)
6.3.2 Global Bio-based Pentylenediamine Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada Bio-based Pentylenediamine Market Size by Type
7.1.1 US & Canada Bio-based Pentylenediamine Sales by Type (2018-2029)
7.1.2 US & Canada Bio-based Pentylenediamine Revenue by Type (2018-2029)
7.2 US & Canada Bio-based Pentylenediamine Market Size by Application
7.2.1 US & Canada Bio-based Pentylenediamine Sales by Application (2018-2029)
7.2.2 US & Canada Bio-based Pentylenediamine Revenue by Application (2018-2029)
7.3 US & Canada Bio-based Pentylenediamine Sales by Country
7.3.1 US & Canada Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Bio-based Pentylenediamine Sales by Country (2018-2029)
7.3.3 US & Canada Bio-based Pentylenediamine Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 EUROPE
8.1 Europe Bio-based Pentylenediamine Market Size by Type
8.1.1 Europe Bio-based Pentylenediamine Sales by Type (2018-2029)
8.1.2 Europe Bio-based Pentylenediamine Revenue by Type (2018-2029)
8.2 Europe Bio-based Pentylenediamine Market Size by Application
8.2.1 Europe Bio-based Pentylenediamine Sales by Application (2018-2029)
8.2.2 Europe Bio-based Pentylenediamine Revenue by Application (2018-2029)
8.3 Europe Bio-based Pentylenediamine Sales by Country
8.3.1 Europe Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Bio-based Pentylenediamine Sales by Country (2018-2029)
8.3.3 Europe Bio-based Pentylenediamine Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China Bio-based Pentylenediamine Market Size by Type
9.1.1 China Bio-based Pentylenediamine Sales by Type (2018-2029)
9.1.2 China Bio-based Pentylenediamine Revenue by Type (2018-2029)
9.2 China Bio-based Pentylenediamine Market Size by Application
9.2.1 China Bio-based Pentylenediamine Sales by Application (2018-2029)
9.2.2 China Bio-based Pentylenediamine Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia Bio-based Pentylenediamine Market Size by Type
10.1.1 Asia Bio-based Pentylenediamine Sales by Type (2018-2029)
10.1.2 Asia Bio-based Pentylenediamine Revenue by Type (2018-2029)
10.2 Asia Bio-based Pentylenediamine Market Size by Application
10.2.1 Asia Bio-based Pentylenediamine Sales by Application (2018-2029)
10.2.2 Asia Bio-based Pentylenediamine Revenue by Application (2018-2029)
10.3 Asia Bio-based Pentylenediamine Sales by Region
10.3.1 Asia Bio-based Pentylenediamine Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Bio-based Pentylenediamine Revenue by Region (2018-2029)
10.3.3 Asia Bio-based Pentylenediamine Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Market Size by Type
11.1.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Market Size by Application
11.2.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country
11.3.1 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 Cathay Biotech Inc.
12.1.1 Cathay Biotech Inc. Company Information
12.1.2 Cathay Biotech Inc. Overview
12.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Cathay Biotech Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Cathay Biotech Inc. Recent Developments
12.2 Aphena Pharma Solutions
12.2.1 Aphena Pharma Solutions Company Information
12.2.2 Aphena Pharma Solutions Overview
12.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Aphena Pharma Solutions Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Aphena Pharma Solutions Recent Developments
12.3 Bio-Tech Pharmacal
12.3.1 Bio-Tech Pharmacal Company Information
12.3.2 Bio-Tech Pharmacal Overview
12.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Bio-Tech Pharmacal Recent Developments
12.4 Goodwin Biotechnology
12.4.1 Goodwin Biotechnology Company Information
12.4.2 Goodwin Biotechnology Overview
12.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Goodwin Biotechnology Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Goodwin Biotechnology Recent Developments
12.5 Xenon Pharmaceuticals
12.5.1 Xenon Pharmaceuticals Company Information
12.5.2 Xenon Pharmaceuticals Overview
12.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Xenon Pharmaceuticals Recent Developments
12.6 Nektar Therapeutics
12.6.1 Nektar Therapeutics Company Information
12.6.2 Nektar Therapeutics Overview
12.6.3 Nektar Therapeutics Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Nektar Therapeutics Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Nektar Therapeutics Recent Developments
12.7 Midas Pharmaceuticals
12.7.1 Midas Pharmaceuticals Company Information
12.7.2 Midas Pharmaceuticals Overview
12.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Midas Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Midas Pharmaceuticals Recent Developments
12.8 Kedrion Biopharma
12.8.1 Kedrion Biopharma Company Information
12.8.2 Kedrion Biopharma Overview
12.8.3 Kedrion Biopharma Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Kedrion Biopharma Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Kedrion Biopharma Recent Developments
12.9 Xcelthera
12.9.1 Xcelthera Company Information
12.9.2 Xcelthera Overview
12.9.3 Xcelthera Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Xcelthera Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Xcelthera Recent Developments
12.10 Anichem
12.10.1 Anichem Company Information
12.10.2 Anichem Overview
12.10.3 Anichem Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Anichem Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Anichem Recent Developments
12.11 ALC Bio Innovations
12.11.1 ALC Bio Innovations Company Information
12.11.2 ALC Bio Innovations Overview
12.11.3 ALC Bio Innovations Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 ALC Bio Innovations Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 ALC Bio Innovations Recent Developments
12.12 ACADIA Pharmaceuticals
12.12.1 ACADIA Pharmaceuticals Company Information
12.12.2 ACADIA Pharmaceuticals Overview
12.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 ACADIA Pharmaceuticals Recent Developments
12.13 AbbVie Inc.
12.13.1 AbbVie Inc. Company Information
12.13.2 AbbVie Inc. Overview
12.13.3 AbbVie Inc. Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 AbbVie Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 AbbVie Inc. Recent Developments
12.14 Ology Bioservices
12.14.1 Ology Bioservices Company Information
12.14.2 Ology Bioservices Overview
12.14.3 Ology Bioservices Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Ology Bioservices Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Ology Bioservices Recent Developments
12.15 QMI - Quality Management
12.15.1 QMI - Quality Management Company Information
12.15.2 QMI - Quality Management Overview
12.15.3 QMI - Quality Management Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.15.4 QMI - Quality Management Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 QMI - Quality Management Recent Developments
12.16 Biomiga
12.16.1 Biomiga Company Information
12.16.2 Biomiga Overview
12.16.3 Biomiga Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.16.4 Biomiga Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Biomiga Recent Developments
12.17 Molecular Targeting Technologies
12.17.1 Molecular Targeting Technologies Company Information
12.17.2 Molecular Targeting Technologies Overview
12.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.17.4 Molecular Targeting Technologies Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Molecular Targeting Technologies Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 Bio-based Pentylenediamine Industry Chain Analysis
13.2 Bio-based Pentylenediamine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Bio-based Pentylenediamine Production Mode & Process
13.4 Bio-based Pentylenediamine Sales and Marketing
13.4.1 Bio-based Pentylenediamine Sales Channels
13.4.2 Bio-based Pentylenediamine Distributors
13.5 Bio-based Pentylenediamine Customers
14 BIO-BASED PENTYLENEDIAMINE MARKET DYNAMICS
14.1 Bio-based Pentylenediamine Industry Trends
14.2 Bio-based Pentylenediamine Market Drivers
14.3 Bio-based Pentylenediamine Market Challenges
14.4 Bio-based Pentylenediamine Market Restraints
15 KEY FINDING IN THE GLOBAL BIO-BASED PENTYLENEDIAMINE STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Bio-based Pentylenediamine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Polyamide
Table 3. Major Manufacturers of PDI
Table 4. Major Manufacturers of Epoxy Curing Agent
Table 5. Major Manufacturers of Organic Synthesis Intermediate
Table 6. Major Manufacturers of Others
Table 7. Global Bio-based Pentylenediamine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Bio-based Pentylenediamine Production by Region: 2018 VS 2022 VS 2029 (Tons)
Table 9. Global Bio-based Pentylenediamine Production by Region (2018-2023) & (Tons)
Table 10. Global Bio-based Pentylenediamine Production by Region (2024-2029) & (Tons)
Table 11. Global Bio-based Pentylenediamine Production Market Share by Region (2018-2023)
Table 12. Global Bio-based Pentylenediamine Production Market Share by Region (2024-2029)
Table 13. Global Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Bio-based Pentylenediamine Revenue by Region (2018-2023) & (US$ Million)
Table 15. Global Bio-based Pentylenediamine Revenue by Region (2024-2029) & (US$ Million)
Table 16. Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2023)
Table 17. Global Bio-based Pentylenediamine Revenue Market Share by Region (2024-2029)
Table 18. Global Bio-based Pentylenediamine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 19. Global Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 20. Global Bio-based Pentylenediamine Sales by Region (2024-2029) & (Tons)
Table 21. Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2023)
Table 22. Global Bio-based Pentylenediamine Sales Market Share by Region (2024-2029)
Table 23. Global Bio-based Pentylenediamine Sales by Manufacturers (2018-2023) & (Tons)
Table 24. Global Bio-based Pentylenediamine Sales Share by Manufacturers (2018-2023)
Table 25. Global Bio-based Pentylenediamine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 26. Global Bio-based Pentylenediamine Revenue Share by Manufacturers (2018-2023)
Table 27. Bio-based Pentylenediamine Price by Manufacturers 2018-2023 (US$/Ton)
Table 28. Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2021 VS 2022 VS 2023
Table 29. Global Bio-based Pentylenediamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Bio-based Pentylenediamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-based Pentylenediamine as of 2022)
Table 31. Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters
Table 32. Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application
Table 33. Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 36. Global Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 37. Global Bio-based Pentylenediamine Sales Share by Type (2018-2023)
Table 38. Global Bio-based Pentylenediamine Sales Share by Type (2024-2029)
Table 39. Global Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 40. Global Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 41. Global Bio-based Pentylenediamine Revenue Share by Type (2018-2023)
Table 42. Global Bio-based Pentylenediamine Revenue Share by Type (2024-2029)
Table 43. Bio-based Pentylenediamine Price by Type (2018-2023) & (US$/Ton)
Table 44. Global Bio-based Pentylenediamine Price Forecast by Type (2024-2029) & (US$/Ton)
Table 45. Global Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 46. Global Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 47. Global Bio-based Pentylenediamine Sales Share by Application (2018-2023)
Table 48. Global Bio-based Pentylenediamine Sales Share by Application (2024-2029)
Table 49. Global Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 50. Global Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 51. Global Bio-based Pentylenediamine Revenue Share by Application (2018-2023)
Table 52. Global Bio-based Pentylenediamine Revenue Share by Application (2024-2029)
Table 53. Bio-based Pentylenediamine Price by Application (2018-2023) & (US$/Ton)
Table 54. Global Bio-based Pentylenediamine Price Forecast by Application (2024-2029) & (US$/Ton)
Table 55. US & Canada Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 56. US & Canada Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 57. US & Canada Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 58. US & Canada Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 59. US & Canada Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 60. US & Canada Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 61. US & Canada Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 62. US & Canada Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 63. US & Canada Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 64. US & Canada Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 65. US & Canada Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 66. US & Canada Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 67. US & Canada Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 68. Europe Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 69. Europe Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 70. Europe Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 72. Europe Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 73. Europe Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 74. Europe Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 76. Europe Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 77. Europe Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 79. Europe Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 80. Europe Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 81. China Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 82. China Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 83. China Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 85. China Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 86. China Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 87. China Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 90. Asia Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 91. Asia Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 92. Asia Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 93. Asia Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 94. Asia Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 95. Asia Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 96. Asia Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 97. Asia Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. Asia Bio-based Pentylenediamine Revenue by Region (2018-2023) & (US$ Million)
Table 99. Asia Bio-based Pentylenediamine Revenue by Region (2024-2029) & (US$ Million)
Table 100. Asia Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 101. Asia Bio-based Pentylenediamine Sales by Region (2024-2029) & (Tons)
Table 102. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 103. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 104. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 107. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 108. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 113. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 114. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 115. Cathay Biotech Inc. Company Information
Table 116. Cathay Biotech Inc. Description and Major Businesses
Table 117. Cathay Biotech Inc. Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. Cathay Biotech Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Cathay Biotech Inc. Recent Development
Table 120. Aphena Pharma Solutions Company Information
Table 121. Aphena Pharma Solutions Description and Major Businesses
Table 122. Aphena Pharma Solutions Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Aphena Pharma Solutions Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Aphena Pharma Solutions Recent Development
Table 125. Bio-Tech Pharmacal Company Information
Table 126. Bio-Tech Pharmacal Description and Major Businesses
Table 127. Bio-Tech Pharmacal Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. Bio-Tech Pharmacal Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bio-Tech Pharmacal Recent Development
Table 130. Goodwin Biotechnology Company Information
Table 131. Goodwin Biotechnology Description and Major Businesses
Table 132. Goodwin Biotechnology Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. Goodwin Biotechnology Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Goodwin Biotechnology Recent Development
Table 135. Xenon Pharmaceuticals Company Information
Table 136. Xenon Pharmaceuticals Description and Major Businesses
Table 137. Xenon Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Xenon Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Xenon Pharmaceuticals Recent Development
Table 140. Nektar Therapeutics Company Information
Table 141. Nektar Therapeutics Description and Major Businesses
Table 142. Nektar Therapeutics Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. Nektar Therapeutics Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Nektar Therapeutics Recent Development
Table 145. Midas Pharmaceuticals Company Information
Table 146. Midas Pharmaceuticals Description and Major Businesses
Table 147. Midas Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Midas Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Midas Pharmaceuticals Recent Development
Table 150. Kedrion Biopharma Company Information
Table 151. Kedrion Biopharma Description and Major Businesses
Table 152. Kedrion Biopharma Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Kedrion Biopharma Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Kedrion Biopharma Recent Development
Table 155. Xcelthera Company Information
Table 156. Xcelthera Description and Major Businesses
Table 157. Xcelthera Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Xcelthera Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Xcelthera Recent Development
Table 160. Anichem Company Information
Table 161. Anichem Description and Major Businesses
Table 162. Anichem Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. Anichem Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Anichem Recent Development
Table 165. ALC Bio Innovations Company Information
Table 166. ALC Bio Innovations Description and Major Businesses
Table 167. ALC Bio Innovations Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 168. ALC Bio Innovations Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. ALC Bio Innovations Recent Development
Table 170. ACADIA Pharmaceuticals Company Information
Table 171. ACADIA Pharmaceuticals Description and Major Businesses
Table 172. ACADIA Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 173. ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ACADIA Pharmaceuticals Recent Development
Table 175. AbbVie Inc. Company Information
Table 176. AbbVie Inc. Description and Major Businesses
Table 177. AbbVie Inc. Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 178. AbbVie Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. AbbVie Inc. Recent Development
Table 180. Ology Bioservices Company Information
Table 181. Ology Bioservices Description and Major Businesses
Table 182. Ology Bioservices Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 183. Ology Bioservices Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Ology Bioservices Recent Development
Table 185. QMI - Quality Management Company Information
Table 186. QMI - Quality Management Description and Major Businesses
Table 187. QMI - Quality Management Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 188. QMI - Quality Management Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. QMI - Quality Management Recent Development
Table 190. Biomiga Company Information
Table 191. Biomiga Description and Major Businesses
Table 192. Biomiga Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 193. Biomiga Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Biomiga Recent Development
Table 195. Molecular Targeting Technologies Company Information
Table 196. Molecular Targeting Technologies Description and Major Businesses
Table 197. Molecular Targeting Technologies Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 198. Molecular Targeting Technologies Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Molecular Targeting Technologies Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Bio-based Pentylenediamine Distributors List
Table 203. Bio-based Pentylenediamine Customers List
Table 204. Bio-based Pentylenediamine Market Trends
Table 205. Bio-based Pentylenediamine Market Drivers
Table 206. Bio-based Pentylenediamine Market Challenges
Table 207. Bio-based Pentylenediamine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 1. Global Bio-based Pentylenediamine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Polyamide
Table 3. Major Manufacturers of PDI
Table 4. Major Manufacturers of Epoxy Curing Agent
Table 5. Major Manufacturers of Organic Synthesis Intermediate
Table 6. Major Manufacturers of Others
Table 7. Global Bio-based Pentylenediamine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Bio-based Pentylenediamine Production by Region: 2018 VS 2022 VS 2029 (Tons)
Table 9. Global Bio-based Pentylenediamine Production by Region (2018-2023) & (Tons)
Table 10. Global Bio-based Pentylenediamine Production by Region (2024-2029) & (Tons)
Table 11. Global Bio-based Pentylenediamine Production Market Share by Region (2018-2023)
Table 12. Global Bio-based Pentylenediamine Production Market Share by Region (2024-2029)
Table 13. Global Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Bio-based Pentylenediamine Revenue by Region (2018-2023) & (US$ Million)
Table 15. Global Bio-based Pentylenediamine Revenue by Region (2024-2029) & (US$ Million)
Table 16. Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2023)
Table 17. Global Bio-based Pentylenediamine Revenue Market Share by Region (2024-2029)
Table 18. Global Bio-based Pentylenediamine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 19. Global Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 20. Global Bio-based Pentylenediamine Sales by Region (2024-2029) & (Tons)
Table 21. Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2023)
Table 22. Global Bio-based Pentylenediamine Sales Market Share by Region (2024-2029)
Table 23. Global Bio-based Pentylenediamine Sales by Manufacturers (2018-2023) & (Tons)
Table 24. Global Bio-based Pentylenediamine Sales Share by Manufacturers (2018-2023)
Table 25. Global Bio-based Pentylenediamine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 26. Global Bio-based Pentylenediamine Revenue Share by Manufacturers (2018-2023)
Table 27. Bio-based Pentylenediamine Price by Manufacturers 2018-2023 (US$/Ton)
Table 28. Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2021 VS 2022 VS 2023
Table 29. Global Bio-based Pentylenediamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Bio-based Pentylenediamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-based Pentylenediamine as of 2022)
Table 31. Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters
Table 32. Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application
Table 33. Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 36. Global Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 37. Global Bio-based Pentylenediamine Sales Share by Type (2018-2023)
Table 38. Global Bio-based Pentylenediamine Sales Share by Type (2024-2029)
Table 39. Global Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 40. Global Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 41. Global Bio-based Pentylenediamine Revenue Share by Type (2018-2023)
Table 42. Global Bio-based Pentylenediamine Revenue Share by Type (2024-2029)
Table 43. Bio-based Pentylenediamine Price by Type (2018-2023) & (US$/Ton)
Table 44. Global Bio-based Pentylenediamine Price Forecast by Type (2024-2029) & (US$/Ton)
Table 45. Global Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 46. Global Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 47. Global Bio-based Pentylenediamine Sales Share by Application (2018-2023)
Table 48. Global Bio-based Pentylenediamine Sales Share by Application (2024-2029)
Table 49. Global Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 50. Global Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 51. Global Bio-based Pentylenediamine Revenue Share by Application (2018-2023)
Table 52. Global Bio-based Pentylenediamine Revenue Share by Application (2024-2029)
Table 53. Bio-based Pentylenediamine Price by Application (2018-2023) & (US$/Ton)
Table 54. Global Bio-based Pentylenediamine Price Forecast by Application (2024-2029) & (US$/Ton)
Table 55. US & Canada Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 56. US & Canada Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 57. US & Canada Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 58. US & Canada Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 59. US & Canada Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 60. US & Canada Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 61. US & Canada Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 62. US & Canada Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 63. US & Canada Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 64. US & Canada Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 65. US & Canada Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 66. US & Canada Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 67. US & Canada Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 68. Europe Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 69. Europe Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 70. Europe Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 72. Europe Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 73. Europe Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 74. Europe Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 76. Europe Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 77. Europe Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 79. Europe Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 80. Europe Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 81. China Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 82. China Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 83. China Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 85. China Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 86. China Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 87. China Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 90. Asia Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 91. Asia Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 92. Asia Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 93. Asia Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 94. Asia Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 95. Asia Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 96. Asia Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 97. Asia Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 98. Asia Bio-based Pentylenediamine Revenue by Region (2018-2023) & (US$ Million)
Table 99. Asia Bio-based Pentylenediamine Revenue by Region (2024-2029) & (US$ Million)
Table 100. Asia Bio-based Pentylenediamine Sales by Region (2018-2023) & (Tons)
Table 101. Asia Bio-based Pentylenediamine Sales by Region (2024-2029) & (Tons)
Table 102. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2018-2023) & (Tons)
Table 103. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Type (2024-2029) & (Tons)
Table 104. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Type (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2018-2023) & (Tons)
Table 107. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Application (2024-2029) & (Tons)
Table 108. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Application (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue by Country (2024-2029) & (US$ Million)
Table 113. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2018-2023) & (Tons)
Table 114. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales by Country (2024-2029) & (Tons)
Table 115. Cathay Biotech Inc. Company Information
Table 116. Cathay Biotech Inc. Description and Major Businesses
Table 117. Cathay Biotech Inc. Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. Cathay Biotech Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Cathay Biotech Inc. Recent Development
Table 120. Aphena Pharma Solutions Company Information
Table 121. Aphena Pharma Solutions Description and Major Businesses
Table 122. Aphena Pharma Solutions Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Aphena Pharma Solutions Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Aphena Pharma Solutions Recent Development
Table 125. Bio-Tech Pharmacal Company Information
Table 126. Bio-Tech Pharmacal Description and Major Businesses
Table 127. Bio-Tech Pharmacal Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. Bio-Tech Pharmacal Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bio-Tech Pharmacal Recent Development
Table 130. Goodwin Biotechnology Company Information
Table 131. Goodwin Biotechnology Description and Major Businesses
Table 132. Goodwin Biotechnology Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. Goodwin Biotechnology Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Goodwin Biotechnology Recent Development
Table 135. Xenon Pharmaceuticals Company Information
Table 136. Xenon Pharmaceuticals Description and Major Businesses
Table 137. Xenon Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Xenon Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Xenon Pharmaceuticals Recent Development
Table 140. Nektar Therapeutics Company Information
Table 141. Nektar Therapeutics Description and Major Businesses
Table 142. Nektar Therapeutics Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. Nektar Therapeutics Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Nektar Therapeutics Recent Development
Table 145. Midas Pharmaceuticals Company Information
Table 146. Midas Pharmaceuticals Description and Major Businesses
Table 147. Midas Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Midas Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Midas Pharmaceuticals Recent Development
Table 150. Kedrion Biopharma Company Information
Table 151. Kedrion Biopharma Description and Major Businesses
Table 152. Kedrion Biopharma Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Kedrion Biopharma Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Kedrion Biopharma Recent Development
Table 155. Xcelthera Company Information
Table 156. Xcelthera Description and Major Businesses
Table 157. Xcelthera Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Xcelthera Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Xcelthera Recent Development
Table 160. Anichem Company Information
Table 161. Anichem Description and Major Businesses
Table 162. Anichem Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. Anichem Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Anichem Recent Development
Table 165. ALC Bio Innovations Company Information
Table 166. ALC Bio Innovations Description and Major Businesses
Table 167. ALC Bio Innovations Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 168. ALC Bio Innovations Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. ALC Bio Innovations Recent Development
Table 170. ACADIA Pharmaceuticals Company Information
Table 171. ACADIA Pharmaceuticals Description and Major Businesses
Table 172. ACADIA Pharmaceuticals Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 173. ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ACADIA Pharmaceuticals Recent Development
Table 175. AbbVie Inc. Company Information
Table 176. AbbVie Inc. Description and Major Businesses
Table 177. AbbVie Inc. Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 178. AbbVie Inc. Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. AbbVie Inc. Recent Development
Table 180. Ology Bioservices Company Information
Table 181. Ology Bioservices Description and Major Businesses
Table 182. Ology Bioservices Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 183. Ology Bioservices Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Ology Bioservices Recent Development
Table 185. QMI - Quality Management Company Information
Table 186. QMI - Quality Management Description and Major Businesses
Table 187. QMI - Quality Management Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 188. QMI - Quality Management Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. QMI - Quality Management Recent Development
Table 190. Biomiga Company Information
Table 191. Biomiga Description and Major Businesses
Table 192. Biomiga Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 193. Biomiga Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Biomiga Recent Development
Table 195. Molecular Targeting Technologies Company Information
Table 196. Molecular Targeting Technologies Description and Major Businesses
Table 197. Molecular Targeting Technologies Bio-based Pentylenediamine Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 198. Molecular Targeting Technologies Bio-based Pentylenediamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Molecular Targeting Technologies Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Bio-based Pentylenediamine Distributors List
Table 203. Bio-based Pentylenediamine Customers List
Table 204. Bio-based Pentylenediamine Market Trends
Table 205. Bio-based Pentylenediamine Market Drivers
Table 206. Bio-based Pentylenediamine Market Challenges
Table 207. Bio-based Pentylenediamine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Bio-based Pentylenediamine Product Picture
Figure 2. Global Bio-based Pentylenediamine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bio-based Pentylenediamine Market Share by Type in 2022 & 2029
Figure 4. Polyamide Product Picture
Figure 5. PDI Product Picture
Figure 6. Epoxy Curing Agent Product Picture
Figure 7. Organic Synthesis Intermediate Product Picture
Figure 8. Others Product Picture
Figure 9. Global Bio-based Pentylenediamine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Bio-based Pentylenediamine Market Share by Application in 2022 & 2029
Figure 11. Spinning
Figure 12. Engineering Materials
Figure 13. Medicine
Figure 14. Pesticides
Figure 15. Organic Synthesis
Figure 16. Others
Figure 17. Bio-based Pentylenediamine Report Years Considered
Figure 18. Global Bio-based Pentylenediamine Capacity, Production and Utilization (2018-2029) & (Tons)
Figure 19. Global Bio-based Pentylenediamine Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Bio-based Pentylenediamine Production Market Share by Region (2018-2029)
Figure 21. Bio-based Pentylenediamine Production Growth Rate in North America (2018-2029) & (Tons)
Figure 22. Bio-based Pentylenediamine Production Growth Rate in Europe (2018-2029) & (Tons)
Figure 23. Bio-based Pentylenediamine Production Growth Rate in China (2018-2029) & (Tons)
Figure 24. Bio-based Pentylenediamine Production Growth Rate in Japan (2018-2029) & (Tons)
Figure 25. Global Bio-based Pentylenediamine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 26. Global Bio-based Pentylenediamine Revenue 2018-2029 (US$ Million)
Figure 27. Global Bio-based Pentylenediamine Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 28. Global Bio-based Pentylenediamine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 29. Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2029)
Figure 30. Global Bio-based Pentylenediamine Sales 2018-2029 ((Tons)
Figure 31. Global Bio-based Pentylenediamine Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 32. Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2029)
Figure 33. US & Canada Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 34. US & Canada Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 35. Europe Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 36. Europe Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 37. China Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 38. China Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 39. Asia (excluding China) Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 40. Asia (excluding China) Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 41. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 42. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 43. The Bio-based Pentylenediamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 44. The Top 5 and 10 Largest Manufacturers of Bio-based Pentylenediamine in the World: Market Share by Bio-based Pentylenediamine Revenue in 2022
Figure 45. Global Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 46. Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 47. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 48. Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 49. Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 50. US & Canada Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 51. US & Canada Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 52. US & Canada Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 53. US & Canada Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 54. US & Canada Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 55. US & Canada Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 56. U.S. Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 57. Canada Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 58. Europe Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 59. Europe Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 60. Europe Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 61. Europe Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 62. Europe Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 63. Europe Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 64. Germany Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 65. France Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 66. U.K. Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 67. Italy Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 68. Russia Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 69. China Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 70. China Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 71. China Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 72. China Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 73. Asia Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 74. Asia Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 75. Asia Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 76. Asia Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 77. Asia Bio-based Pentylenediamine Revenue Share by Region (2018-2029)
Figure 78. Asia Bio-based Pentylenediamine Sales Share by Region (2018-2029)
Figure 79. Japan Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 80. South Korea Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 81. China Taiwan Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 82. Southeast Asia Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 83. India Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 84. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 85. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 86. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 87. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 88. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 89. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 90. Brazil Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 91. Mexico Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 92. Turkey Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 93. Israel Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 94. GCC Countries Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 95. Bio-based Pentylenediamine Value Chain
Figure 96. Bio-based Pentylenediamine Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
Figure 1. Bio-based Pentylenediamine Product Picture
Figure 2. Global Bio-based Pentylenediamine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bio-based Pentylenediamine Market Share by Type in 2022 & 2029
Figure 4. Polyamide Product Picture
Figure 5. PDI Product Picture
Figure 6. Epoxy Curing Agent Product Picture
Figure 7. Organic Synthesis Intermediate Product Picture
Figure 8. Others Product Picture
Figure 9. Global Bio-based Pentylenediamine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Bio-based Pentylenediamine Market Share by Application in 2022 & 2029
Figure 11. Spinning
Figure 12. Engineering Materials
Figure 13. Medicine
Figure 14. Pesticides
Figure 15. Organic Synthesis
Figure 16. Others
Figure 17. Bio-based Pentylenediamine Report Years Considered
Figure 18. Global Bio-based Pentylenediamine Capacity, Production and Utilization (2018-2029) & (Tons)
Figure 19. Global Bio-based Pentylenediamine Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Bio-based Pentylenediamine Production Market Share by Region (2018-2029)
Figure 21. Bio-based Pentylenediamine Production Growth Rate in North America (2018-2029) & (Tons)
Figure 22. Bio-based Pentylenediamine Production Growth Rate in Europe (2018-2029) & (Tons)
Figure 23. Bio-based Pentylenediamine Production Growth Rate in China (2018-2029) & (Tons)
Figure 24. Bio-based Pentylenediamine Production Growth Rate in Japan (2018-2029) & (Tons)
Figure 25. Global Bio-based Pentylenediamine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 26. Global Bio-based Pentylenediamine Revenue 2018-2029 (US$ Million)
Figure 27. Global Bio-based Pentylenediamine Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 28. Global Bio-based Pentylenediamine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 29. Global Bio-based Pentylenediamine Revenue Market Share by Region (2018-2029)
Figure 30. Global Bio-based Pentylenediamine Sales 2018-2029 ((Tons)
Figure 31. Global Bio-based Pentylenediamine Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 32. Global Bio-based Pentylenediamine Sales Market Share by Region (2018-2029)
Figure 33. US & Canada Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 34. US & Canada Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 35. Europe Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 36. Europe Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 37. China Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 38. China Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 39. Asia (excluding China) Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 40. Asia (excluding China) Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 41. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales YoY (2018-2029) & (Tons)
Figure 42. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue YoY (2018-2029) & (US$ Million)
Figure 43. The Bio-based Pentylenediamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 44. The Top 5 and 10 Largest Manufacturers of Bio-based Pentylenediamine in the World: Market Share by Bio-based Pentylenediamine Revenue in 2022
Figure 45. Global Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 46. Global Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 47. Global Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 48. Global Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 49. Global Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 50. US & Canada Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 51. US & Canada Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 52. US & Canada Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 53. US & Canada Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 54. US & Canada Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 55. US & Canada Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 56. U.S. Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 57. Canada Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 58. Europe Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 59. Europe Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 60. Europe Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 61. Europe Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 62. Europe Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 63. Europe Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 64. Germany Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 65. France Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 66. U.K. Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 67. Italy Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 68. Russia Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 69. China Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 70. China Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 71. China Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 72. China Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 73. Asia Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 74. Asia Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 75. Asia Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 76. Asia Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 77. Asia Bio-based Pentylenediamine Revenue Share by Region (2018-2029)
Figure 78. Asia Bio-based Pentylenediamine Sales Share by Region (2018-2029)
Figure 79. Japan Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 80. South Korea Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 81. China Taiwan Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 82. Southeast Asia Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 83. India Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 84. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Market Share by Type (2018-2029)
Figure 85. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Market Share by Type (2018-2029)
Figure 86. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Market Share by Application (2018-2029)
Figure 87. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Market Share by Application (2018-2029)
Figure 88. Middle East, Africa and Latin America Bio-based Pentylenediamine Revenue Share by Country (2018-2029)
Figure 89. Middle East, Africa and Latin America Bio-based Pentylenediamine Sales Share by Country (2018-2029)
Figure 90. Brazil Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 91. Mexico Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 92. Turkey Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 93. Israel Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 94. GCC Countries Bio-based Pentylenediamine Revenue (2018-2029) & (US$ Million)
Figure 95. Bio-based Pentylenediamine Value Chain
Figure 96. Bio-based Pentylenediamine Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
